Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Cox, Michael J ^a   Allgaier, Martin ^a,e   Taylor, Byron ^a,f   Baek, Marshall S ^a   Huang, Yvonne J ^a,d   Daly, Rebecca A ^b,c   Karaoz, Ulas ^b   Andersen, Gary L ^b   Brown, Ronald ^a   Fujimura, Kei E ^a   Wu, Brian ^a,d   Tran, Diem ^d   Koff, Jonathan ^a,d   Kleinhenz, Mary Ellen ^a,d   Nielson, Dennis ^a,d   Brodie, Eoin L ^b   Lynch, Susan V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DOE JOINT GENOME INSTITUTE   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; PRIMER DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AIRWAY MICROBIOTA; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; ENTEROBACTERIACEAE; GENE IDENTIFICATION; GENOTYPE; HUMAN; INFANT; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MICROBIAL COMMUNITY; MICROFLORA; MORAXELLACEAE; NONHUMAN; PHYLOGENY; POPULATION ABUNDANCE; PSEUDOMONADACEAE; SPUTUM ANALYSIS; THROAT CULTURE; XANTHOMONADACEAE; DNA MICROARRAY; GENETICS; MICROBIOLOGY; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; VALIDATION STUDY;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; MORAXELLACEAE; PSEUDOMONADACEAE; XANTHOMONADACEAE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA PRIMERS; HUMANS; INFANT; MIDDLE AGED; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 77955292433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011044     Document Type: Article

References (76)

1. Amadori A, Antonelli A, Balteri I, Schreiber A, Bugiani M, et al. (2009) Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis. Respir Med 103: 407-413.
2. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, et al. (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2: 204.
3. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, et al. (2008) Antibioticinduced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 76: 4726-4736.
4. Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
5. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D, Garcia-Gil LJ (2006) Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis 12: 1136-1145.
6. Kumar PS, Griffen AL, Barton JA, Paster BJ, Moeschberger ML, et al. (2003) New bacterial species associated with chronic periodontitis. J Dent Res 82: 338-344.
7. Kumar PS, Leys EJ, Bryk JM, Martinez FJ, Moeschberger ML, et al. (2006) Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol 44: 3665-3673.
8. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, et al. (2008) A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 105: 15070-15075.
9. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.
10. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, et al. (2007) Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A 104: 20529-20533.
11. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, et al. (2004) characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 42: 5176-5183.
12. Rogers GB, Hart CA, Mason JR, Hughes M, Walshaw MJ, et al. (2003) Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 41: 3548-3558.
13. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Kehagia V, et al. (2005) Bacterial activity in cystic fibrosis lung infections. Respir Res 6: 49.
14. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, et al. (2006) Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 44: 2601-2604.
15. Bittar F, Richet H, Dubus J-C, Reynaud-Gaubert M, Stremler N, et al. (2008) Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients. PLoS ONE 3: e2908.
16. Kolak M, Karpati F, Monstein HJ, Jonasson J (2003) Molecular typing of the bacterial flora in sputum of cystic fibrosis patients. Int J Med Microbiol 293: 309-317.
17. Brodie EL, DeSantis TZ, Joyner DC, Baek SM, Larsen JT, et al. (2006) Application of a High-Density Oligonucleotide Microarray Approach To Study Bacterial Population Dynamics during Uranium Reduction and Reoxidation. Appl Environ Microbiol 72: 6288-6298.
18. Brodie EL, DeSantis TZ, Parker JP, Zubietta IX, Piceno YM, et al. (2007) Urban aerosols harbor diverse and dynamic bacterial populations. Proc Natl Acad Sci U S A 104: 299-304.
19. DeSantis TZ, Brodie EL, Moberg JP, Zubieta IX, Piceno YM, et al. (2007) High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment. Microb Ecol 53: 371-383.
20. Lane DJ (1991) 16S/23S rRNA sequencing. In: Stachebrandt E, Goodfellow M, eds. Nucleic acid techniques in bacterial systematics. Chichester, NY: Wiley.
21. Flanagan JL, Brodie EL, Weng L, Lynch SV, Garcia O, et al. (2007) Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa. J Clin Microbiol 45: 1954-1962.
22. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, et al. (2006) Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB. Appl Environ Microbiol 72: 5069-5072.
23. Team RDC (2008) R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
24. Hamady M, Lozupone C, Knight R (2009) Fast UniFrac: Facilitating highthroughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME Journal (In review).
25. Ludwig W, Strunk O, Westram R, Richter L, Meier H, et al. (2004) ARB: a software environment for sequence data. Nucleic Acids Research 32: 1363-1371.
26. Oksanen J, Kindt R, Legendre P, O'Hara B, Simpson GL, et al. (2008) vegan: Community Ecology Package. R package version 1: 16-1.
27. Webb CO, Ackerly DD, McPeek MA, Donoghue MJ (2002) Phylogenies and community ecology. Annual Review of Ecology and Systematics 33: 475-505.
28. Webb CO, Losos JB, Agrawal AA (2006) Integrating phylogenies into community ecology. Ecology 87: S1-S2
29. Kembel S, Ackerly D, Blomberg S, Cowan P, Helmus M, et al. (2008) picante: Tools for Integrating Phylogenies and Ecology. R package version 0: 4-0.
30. Price MN, Dehal PS, Arkin AP (2009) FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol 26: 1641-1650.
31. Hill MO (1973) Diversity and evenness: a unifying notation and its consequences. Ecology 54: 427-432.
32. Pielou EC (1966) Measurement of Diversity in Different Types of Biological Collections. Journal of Theoretical Biology 13: 131
33. Pollard KS, Ge Y, Taylor S, Dudoit S Multtest: Resampling-based multiple hypothesis testing. R package version 1.20.0.
34. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
35. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I (2001) Controlling the false discovery rate in behavior genetics research. Behavioural Brain Research 125: 279-284.
36. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440-9445.
37. Letunic I, Bork P (2007) Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics 23: 127-128.
38. Huber T, Faulkner G, Hugenholtz P (2004) Bellerophon: a program to detect chimeric sequences in multiple sequence alignments. Bioinformatics 20: 2317-2319.
39. Webb CO, Ackerly DD, Kembel SW (2008) Phylocom: software for the analysis of phylogenetic community structure and trait evolution. Bioinformatics 24: 2098-2100.
40. Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, et al. (2009) Respiratory Microbiology of Patients With Cystic Fibrosis in the United States. 1995-2005. hest.
41. Souza HA, Nogueira KS, Matos AP, Vieira RP, Riedi CA, et al. (2006) Early microbial colonization of cystic fibrosis patients identified by neonatal screening, with emphasis on Staphylococcus aureus. J Pediatr (Rio J) 82: 377-382.
42. Hoiby N (1988) Hemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis. Chest 94: 97S-103S.
43. Saiman L (2004) Microbiology of early CF lung disease. Paediatr Respir Rev 5 Suppl A: S367-369.
44. Hogardt M, Schreff AM, Naumann L, Reischl U, Sing A (2008) Mycobacterium monacense in a patient with a pulmonary tumor. Jpn J Infect Dis 61: 77-78.
45. Hahn DL, Azenabor AA, Beatty WL, Byrne GI (2002) Chlamydia pneumoniae as a respiratory pathogen. Front Biosci 7: e66-76.
46. Jahn HU, Krull M, Wuppermann FN, Klucken AC, Rosseau S, et al. (2000) Infection and activation of airway epithelial cells by Chlamydia pneumoniae. J Infect Dis 182: 1678-1687.
47. Atkinson TP, Balish MF, Waites KB (2008) Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 32: 956-973.
48. Roberts RC, Nelles LP, Treuhaft MW, Marx JJ, Jr. (1983) Isolation and possible relevance of Thermoactinomyces candidus proteinases in farmer's lung disease. Infect Immun 40: 553-562.
49. Shen YE, Kurup VP, Fink JN (1991) Circulating antibodies against thermophilic actinomycetes in farmers and mushroom workers. J Hyg Epidemiol Microbiol Immunol 35: 309-316.
50. Bittar F, Richet H, Dubus JC, Reynaud-Gaubert M, Stremler N, et al. (2008) Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One 3: e2908.
51. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, et al. (2008) Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177: 995-1001.
52. Coenye T, Goris J, Spilker T, Vandamme P, LiPuma JJ (2002) Characterization of Unusual Bacteria Isolated from Respiratory Secretions of Cystic Fibrosis Patients and Description of Inquilinus limosus gen. nov., sp. nov. Journal of Clinical Microbiology 40: 2062-2069.
53. Armougom F, Bittar F, Stremler N, Rolain JM, Robert C, et al. (2009) Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing. Eur J Clin Microbiol Infect Dis 28: 1151-1154.
54. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
55. Wardle DA, Hornberg G, Zackrisson O, Kalela-Brundin M, Coomes DA (2003) Long-term effects of wildfire on ecosystem properties across an island area gradient. Science 300: 972-975.
56. Tilman D, Reich PB, Knops J, Wedin D, Mielke T, et al. (2001) Diversity and productivity in a long-term grassland experiment. Science 294: 843-845.
57. van der Heijden MG, Bardgett RD, van Straalen NM (2008) The unseen majority: soil microbes as drivers of plant diversity and productivity in terrestrial ecosystems. Ecol Lett 11: 296-310.
58. Connell JH, Slatyer RO (1977) Mechanisms of succession in natural communities and their role in community stability and organization. The American Naturalist 111: 1119-1144.
59. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO (2007) Development of the human infant intestinal microbiota. PLoS Biol 5: e177.
60. Jackson CR (2003) Changes in community properties during microbial succession. OIKOS 101: 444-448.
61. Marcante S, Winkler E, Erschbamer B (2009) Population dynamics along a primary succession gradient: do alpine species fit into demographic succession theory? Ann Bot (Lond) 103: 1129-1143.
62. Zhang GS, Wang RQ, Song BM (2007) Plant community succession in modern Yellow River Delta, China. J Zhejiang Univ Sci B 8: 540-548.
63. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, et al. (2009) Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367-2375.
64. Bowman CM (2002) The long-term use of inhaled tobramycin in patients with cystic fibrosis. J Cyst Fibros 1: 194-198.
65. Stecher B, Chaffron S, Kappeli R, Hapfelmeier S, Freedrich S, et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog 6: e1000711.
66. McKenna P, Hoffmann C, Minkah N, Aye PP, Lackner A, et al. (2008) The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog 4: e20.
67. Lawley TD, Bouley DM, Hoy YE, Gerke C, Relman DA, et al. (2008) Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun 76: 403-416.
68. Flanagan JL, Brodie EL, Weng L, Lynch SV, Garcia O, et al. (2007) Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 45: 1954-1962.
69. Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, et al. (2009) Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun.
70. Song Y, Salinas D, Nielson DW, Verkman AS (2006) Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis. Am J Physiol Cell Physiol 290: C741-749.
71. Widdicombe JH (2001) Altered NaCl concentration of airway surface liquid in cystic fibrosis. Pflugers Arch 443 Suppl 1: S8-10.
72. Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ (1998) Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell 2: 397-403.
73. Murphy TF, Parameswaran GI (2009) Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis 49: 124-131.
74. Meyer EH, Goya S, Akbari O, Berry GJ, Savage PB, et al. (2006) Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci U S A 103: 2782-2787.
75. Kerem B, Kerem E (1996) The molecular basis for disease variability in cystic fibrosis. Eur J Hum Genet 4: 65-73.
76. Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, et al. (2007) Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin Nutr 26: 322-328.